HOPE-3 and SPRINT: two landmark trials with different outcomes?
Cardiovascular Institute, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA. Electronic address: kostis@rwjms.rutgers.edu.
John B
JB
Kostis
Department of Vascular Biology and Hypertension, Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, AL, USA.
Suzanne
S
Oparil
D002986:Clinical Trials as Topic; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*